MetaVia (MTVA)
1.75
-0.09 (4.89%)
Upcoming Events
Latest Headlines
MetaVia Inc. (MTVA) Tops Q2 EPS by 73c
August 7, 2026 8:56 AM - StreetInsider
Form 10-Q MetaVia Inc. For: Jun 30
August 6, 2026 4:34 PM - SEC Filing
Form 8-K MetaVia Inc. For: Aug 06
August 6, 2026 4:07 PM - SEC Filing
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026 4:05 PM - PR NewsWire
H.C. Wainwright Reiterates Buy Rating on MetaVia (MTVA)
July 10, 2026 6:50 AM - StreetInsider
Form 8-K MetaVia Inc. For: Jul 09
July 9, 2026 8:36 AM - SEC Filing
MetaVia completes dose titration in Phase 1 Part 3 obesity trial
July 9, 2026 8:31 AM - StreetInsider
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
July 9, 2026 8:31 AM - PR NewsWire
Form 8-K MetaVia Inc. For: Jul 02
July 2, 2026 4:07 PM - SEC Filing
Form 424B5 MetaVia Inc.
July 2, 2026 4:05 PM - SEC Filing
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
June 17, 2026 8:31 AM - PR NewsWire
Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream
June 10, 2026 7:00 AM - Globe NewsWire
BioStem Technologies appoints three new board members
June 9, 2026 7:00 AM - StreetInsider
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
June 9, 2026 7:00 AM - Globe NewsWire
Form 4 MetaVia Inc. For: Jun 08 Filed by: Tursi James Patrick
June 8, 2026 6:34 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: STRICKLAND D GORDON
June 8, 2026 6:33 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: Salsbury Michael
June 8, 2026 6:32 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: GROVES JASON L
June 8, 2026 6:31 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: KOVEN ANDREW I
June 8, 2026 6:31 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: Glickman Mark A
June 8, 2026 6:29 PM - SEC Filing
Form S-8 MetaVia Inc.
June 8, 2026 4:31 PM - SEC Filing
MetaVia stockholders approve reverse stock split, equity plan expansion
June 8, 2026 4:04 PM - StreetInsider
Form 8-K MetaVia Inc. For: Jun 08
June 8, 2026 4:01 PM - SEC Filing
Form 8-K MetaVia Inc. For: Jun 08
June 8, 2026 9:02 AM - SEC Filing
MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study
June 8, 2026 8:32 AM - StreetInsider
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
June 8, 2026 8:31 AM - PR NewsWire
Full Article List